Serotonin neuron loss and nonmotor symptoms continue in Parkinson's patients treated with dopamine grafts (Q39249440)

10 September 2017

title

Serotonin neuron loss and nonmotor symptoms continue in Parkinson's patients treated with dopamine grafts (English)

1 reference

10 September 2017

0 references

0 references

0 references

1 reference

5

1 reference

10 September 2017

7

Anders Björklund

0 references

Wolfgang H. Oertel

series ordinal

6

object named as

Wolfgang H Oertel

1 reference

10 September 2017

4

Niall P Quinn

1 reference

10 September 2017

1

Marios Politis

1 reference

10 September 2017

9

Paola Piccini

1 reference

10 September 2017

3

Clare Loane

1 reference

10 September 2017

Kit Wu

2

1 reference

10 September 2017

Olle Lindvall

series ordinal

8

1 reference

10 September 2017

language of work or name

English

0 references

publication date

1 April 2012

1 reference

Science Translational Medicine

10 September 2017

published in

1 reference

10 September 2017

volume

4

1 reference

10 September 2017

issue

128

1 reference

10 September 2017

page(s)

128ra41

1 reference

Non-motor symptoms of Parkinson's disease: diagnosis and management

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Parkinson's disease symptoms: the patient's perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Clinical review of treatment options for select nonmotor symptoms of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Dyskinesias after neural transplantation in Parkinson's disease: what do we know and what is next?

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Graft-induced dyskinesias in Parkinson's disease: High striatal serotonin/dopamine transporter ratio.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Staging of brain pathology related to sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Nonmotor symptoms of Parkinson's disease revealed in an animal model with reduced monoamine storage capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Noradrenaline and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Tryptophan hydroxylase 2 aggregates through disulfide cross-linking upon oxidation: possible link to serotonin deficits and non-motor symptoms in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Elevated serotonin transporter binding in depressed patients with Parkinson's disease: a preliminary PET study with [11C]DASB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Serotonin 2A receptors and visual hallucinations in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Fatigue in Parkinson's disease is linked to striatal and limbic serotonergic dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Serotonergic mediated body mass index changes in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Sequential bilateral transplantation in Parkinson's disease: effects of the second graft

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Factors affecting the clinical outcome after neural transplantation in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Monoamine neuron innervation of the normal human brain: an 18F-DOPA PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

The role of the locus coeruleus in the development of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Mechanisms and current treatments of urogenital dysfunction in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Stages in the development of Parkinson's disease-related pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Noradrenaline and 5-hydroxytryptamine modulation of brain dopamine function: implications for the treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Alterations of dopaminergic and noradrenergic innervations in motor cortex in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Immunohistochemical study of the serotoninergic innervation of the basal ganglia in the squirrel monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Aminergic systems in Alzheimer's disease and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

The neuropathologic basis of different clinical subgroups of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Invited Article: Nervous system pathology in sporadic Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Staging of serotonergic dysfunction in Parkinson's disease: an in vivo 11C-DASB PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Serotonin and Parkinson's disease: On movement, mood, and madness

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [(18)F]dopa-PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Extrastriatal monoamine neuron function in Parkinson's disease: an 18F-dopa PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Parametric imaging of ligand-receptor binding in PET using a simplified reference region model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Regional distribution of serotonin transporter protein in postmortem human brain: is the cerebellum a SERT-free brain region?

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Distribution volume ratios without blood sampling from graphical analysis of PET data

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Positron emission tomography quantification of [(11)C]-DASB binding to the human serotonin transporter: modeling strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Consensus nomenclature for in vivo imaging of reversibly binding radioligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

10.1126/SCITRANSLMED.3003391

21 January 2018

Identifiers

DOI

1 reference

10 September 2017

1 reference